Clinical Trials Browser

Interventional × Neoplasms × Cefpodoxime × Clear all

NCT00143533 2017-04-26

Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

Phase 1 Completed

Diarrhea, Neoplasms